National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
UK scientists are putting together a list of the most promising potential cancer drug targets in one of the largest lab studies of its kind.
Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.
A prostate cancer drug won’t be offered on the NHS any earlier in the treatment plans of patients living with the disease in England.
A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.